---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-006350"
form_type: "8-K"
ticker: "GBCS"
cik: "0000727346"
company_name: "SELECTIS HEALTH, INC."
filed_at: "2022-03-09T23:59:59+00:00"
generated_at: "2026-06-27T00:33:11.697424+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Selectis Health CFO Brandon Thall resigns; Controller Christine Lucus named interim CFO

## Summary
- Brandon Thall resigned as CFO effective March 4, 2022; immediate departure.
- Christine Lucus, former Controller, appointed interim CFO effective March 4, 2022.
- Lucus base salary $135,000/year; eligible for $15,000 bonus for timely SEC filings.
- Lucus previously Controller at Neubase Therapeutics (NASDAQ) and has 7 years experience.

## SEC filing metadata
- accession: 0001493152-22-006350
- form_type: 8-K
- ticker: GBCS
- cik: 0000727346
- company_name: SELECTIS HEALTH, INC.
- filed_at: 2022-03-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727346/000149315222006350/0001493152-22-006350-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727346/000149315222006350/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-006350
- JSON: https://secwatch.observer/filing/0001493152-22-006350.json
- Plain text: https://secwatch.observer/filing/0001493152-22-006350.txt

## Key facts
- Executive change
  Brandon Thall resigned as Chief Financial Officer at SELECTIS HEALTH, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Mr. Brandon Thall tendered his resignation as Chief Financial Officer of Selectis Health, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/727346/000149315222006350/0001493152-22-006350-index.htm
- Executive change
  Christine Lucus was appointed as interim Chief Financial Officer at SELECTIS HEALTH, INC..
  - Action: appointed
  - Role: interim Chief Financial Officer
  source text: Christine Lucus, formerly serving as Controller, has been appointed interim CFO of the Company effective March 4, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/727346/000149315222006350/0001493152-22-006350-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.